These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 69503)

  • 21. Facilitation of reentry by lidocaine in canine myocardial infarction.
    Fazekas T; Scherlag BJ; Mabo P; Patterson E; Lazzara R
    Acta Physiol Hung; 1994; 82(3):201-13. PubMed ID: 7717083
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Electroide cather recording during malignant ventricular arrythmia following experimental acute myocardial ischemia. Evidence for re-entry due to conduction delay and block in ischemic myocardium.
    El Sherif N; Scherlag BJ; Lazzara R
    Circulation; 1975 Jun; 51(6):1003-14. PubMed ID: 1132089
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of ventricular parasystole with other dysrhythmias after acute myocardial infarction.
    Baxter RH; McGuinness JB
    Am Heart J; 1974 Oct; 88(4):443-8. PubMed ID: 4137587
    [No Abstract]   [Full Text] [Related]  

  • 24. Failure of lidocaine to suppress lethal ischemic ventricular arrhythmias in a canine model of previous myocardial infarction.
    Lynch JJ; Heaney LA; Wallace AA; Gehret JR; Stein RB
    J Cardiovasc Pharmacol; 1990 Jul; 16(1):41-9. PubMed ID: 1696665
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Current understanding of lidocaine as an antiarrhythmic agent: a review.
    Anderson JL
    Clin Ther; 1984; 6(2):125-41. PubMed ID: 6200230
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lidocaine converts inducible ventricular fibrillation into sustained ventricular tachycardia in conscious dogs with recent myocardial infarction.
    Aidonidis I; Brachmann J; Rizos I; Toutouzas P; Kübler W
    Cardiology; 1994; 85(6):378-87. PubMed ID: 7697673
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Experimental and initial clinical experiences with the new class Ib anti-arrhythmia agent barucainide].
    Gülker H; Heuer H; Frenking B; Haverkamp W; Hindricks G; Bozek B; Bremkes C; Asche KD; Witthöft D
    Z Kardiol; 1988 Sep; 77(9):587-94. PubMed ID: 2461620
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Electrophysiologic actions of BRB-I-28 in ischemically injured canine myocardium.
    Patterson E; Scherlag BJ; Berlin KD; Lazzara R
    J Cardiovasc Pharmacol; 1993 Apr; 21(4):637-46. PubMed ID: 7681911
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Use of lidocaine to treat patients with cardiac rhythm disturbances].
    Doshchitsin VL
    Kardiologiia; 1970 Sep; 10(9):80-6. PubMed ID: 4100492
    [No Abstract]   [Full Text] [Related]  

  • 30. Reentrant ventricular arrhythmias in the late myocardial infarction period: mechanism by which a short-long-short cardiac sequence facilitates the induction of reentry.
    el-Sherif N; Gough WB; Restivo M
    Circulation; 1991 Jan; 83(1):268-78. PubMed ID: 1984885
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reentrant arrhythmias in the subacute infarction period. The proarrhythmic effect of flecainide acetate on functional reentrant circuits.
    Restivo M; Yin H; Caref EB; Patel AI; Ndrepepa G; Avitable MJ; Assadi MA; Isber N; el-Sherif N
    Circulation; 1995 Feb; 91(4):1236-46. PubMed ID: 7850964
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reentrant ventricular arrhythmias in the late myocardial infarction period. 9. Electrophysiologic-anatomic correlation of reentrant circuits.
    Mehra R; Zeiler RH; Gough WB; El-Sherif N
    Circulation; 1983 Jan; 67(1):11-24. PubMed ID: 6183020
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Electrophysiologic effects of sodium channel blockade on anisotropic conduction and conduction block in canine myocardium: preferential slowing of longitudinal conduction by flecainide versus disopyramide or lidocaine.
    Kondo T; Yamaki M; Kubota I; Tachibana H; Tomoike H
    J Am Coll Cardiol; 1997 Jun; 29(7):1639-44. PubMed ID: 9180130
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of disopyramide phosphate on ventricular arrhythmias in experimental myocardial infarction.
    Kus T; Sasyniuk BI
    J Pharmacol Exp Ther; 1976 Mar; 196(3):665-75. PubMed ID: 1263118
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Electrophysiologic study of ischemic ventricular arrhythmia].
    Huang J
    Zhonghua Xin Xue Guan Bing Za Zhi; 1990 Apr; 18(2):110-4, 127. PubMed ID: 2209403
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanisms of bradycardia-induced ventricular arrhythmias in myocardial ischemia and infarction.
    Scherlag BJ; Kabell G; Harrison L; Lazzara R
    Circulation; 1982 Jun; 65(7):1429-34. PubMed ID: 7074798
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of verapamil and lidocaine in a canine model of sudden coronary death.
    Temesy-Armos PN; Legenza M; Southworth SR; Hoffman BF
    J Am Coll Cardiol; 1985 Sep; 6(3):674-81. PubMed ID: 4031280
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of ventricular arrhythmias with mexiletine (Kö 1173).
    Talbot RG; Nimmo J; Julian DG; Clark RA; Neilson JM; Prescott LF
    Lancet; 1973 Aug; 2(7826):399-404. PubMed ID: 4124889
    [No Abstract]   [Full Text] [Related]  

  • 39. Electrophysiological mechanisms of action of ethmozine that explain its antiarrhythmic efficacy in the late stage of experimental myocardial infarction in dogs.
    Aidonidis I; Egel E; Hilbel T; Rizos I; Kuebler W; Brachmann J
    Eur Heart J; 1994 Dec; 15(12):1698-704. PubMed ID: 7698141
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Conduction velocity depression and drug-induced ventricular tachyarrhythmias. Effects of lidocaine in the intact canine heart.
    Anderson KP; Walker R; Lux RL; Ershler PR; Menlove R; Williams MR; Krall R; Moddrelle D
    Circulation; 1990 Mar; 81(3):1024-38. PubMed ID: 2155070
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.